Article Details
Retrieved on: 2021-10-11 05:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities lifted their target price on Ovintiv from $44.00 to $50.00 and gave the stock a "buy" rating in a research report on Thursday.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here